Ian Chau

2 ta ish

Royal Marsden NHS Foundation Trust

1. miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial

   Gayathri Anandappa, Andrea Lampis, David Cunningham +24

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.419961

2. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

   Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider +26

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.769170